contraindications for glp-1 to Antihyperglycemic Medications in Diabetic Complications GLP-1 Medications Infographic | Medidex

Tirzepatide acts on two pathways GLP-1 and GIP for stronger appetite regulation and a broader metabolic response

Results at 72 weeks: Placebo: 3.1% weight loss Tirzepatide 5 mg: 16.0% weight loss (35.3 pounds average) Tirzepatide 10 mg: 21.4% weight loss (49.7 pounds average) Tirzepatide 15 mg: 22.5% weight loss (52.3 pounds average) The percentage of participants achieving 5% or more weight loss was 89% (5 mg), 96% (10 mg), and 96% (15 mg)

That said, semaglutide does not always take the weight off where you want it, which is why you often need other interventions to achieve the look you desire

Hydroxytyrosol, the most studied phenolic compound in olive oil, has shown broad metabolic effects

Note: Prescriptions require an online consultation with a healthcare provider who will determine if a prescription is appropriate